27
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Effect of thalidomide, octreotide, and prednisolone on the migration and proliferation of RPE cells in vitro

, , , &
Pages 483-490 | Published online: 02 Jul 2009

References

  • Young RW. Pathophsiology of age-related macular de-generation. Surv Ophthalmol. 1987;31:291–306.
  • Miller H, Miller B, Ishibashi T, Ryan SJ. Pathogenesis of laser-induced choroidal subretinal neovascularization. Invest Ophthalmol Vis Sci. 1990;31:899–908.
  • Miller H, Miller B, Ryan SJ. The role of retinal pigmentepithelium in the involution of subretinal neovasculari-zation. Invest Ophthalmol Vis Sci. 1986;27:1644–1652.
  • Spraul CW, Lang GE, Yoon HS, Grossniklaus HE, Lang GK. Characteristics and classification of sugically-ex-cised choroidal neovascular membranes. Klin Monatsbl Augenheilkd. 1997;211:324–334.
  • Glaser BM, Campochiaro PA, Davis JL, Jerdan LA. Retinal pigment epithelial cells release inhibitors of neovascularization. Ophthalmology 1987;94:780–784.
  • Glaser BM, Campochiaro PA, Davis JL, Sato M. Reti-nal pigment epithelial cells release an inhibitor of neovascularization. Arch Ophthalmol. 1985; 103 : 1870–1875.
  • Kuijpers RWAM, Vingerling JR, Mooij CM, Van Hagen PM. Treatment of exsudative neovascular macular de- generation with octreotide. Ophthalmic Surg. 1998;30 (Suppl 1):S73.
  • Snyder RK, Runge PE. Thalidomide and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 1998;39 (Suppl):5385.
  • He S, Wang HM, Ye J, Ogden TE, Ryan SJ, Hinton DR. Dexamethasone induced proliferation of cultured retinal pigment epithelial cells. Curr Eye Res. 1994;13:257–261.
  • Ip M, Gorin MB. Recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy treated with daily doses of thalidomide. Am J Ophthalmol. 1996;122:594–595.
  • Ishibashi T, Miki K, Sorgente N. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol. 1985;103:708–711.
  • Joussen M, Kruse FE, Becker M, Rohrschneider K, Völcker HE. Thalidomide inhibits angiogenesis induced by vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 1998;38 (Suppl):S359.
  • Kishimoto N, Uyama M, Fukushima I, Yamada K, Nishikawa M, Ohkuma H. The effect of corticoid on th repair of the retinal pigment epithelium. Nippon Ganka Gakkai Zasshi. 1993;97:360–369.
  • Koutsandrea CN, Miceli MV, Peyman GA, Farahat HG, Niesman MR. Ciprofloxacin and dexamethasone inhibit the proliferation of human retinal pigment epithelial cells in culture. Curr Eye Res. 1991;10:249–258.
  • Luo Q, Peyman GA, Conway MD, Woltering EA. Ef-fect of a somatostatin analog (octreotide acetate) on the growth of retinal pigment epithelial cells in culture. Curr Eye Res. 1996;15:909–913.
  • Penfold P, Gyory J, Hunyor A, Billson F. Exsudative macular degeneration and intravitreal triamcinolone. Aust N Z J Ophthalmol. 1995;23:293–298.
  • Campochiaro PA, Jerdan JA, Glaser BM. Serum contains chemoattractants for human retinal pigment epithelial cells. Arch Ophthalmol. 1984;102:1830–1833.
  • Murphy TL, Sakamoto T, Hinton DR, Spee C, Gundimda UG, Soriano D, Gopalakrishna R, Ryan SJ. Migration of retinal pigment epithelium cells in vitro is regulated by protein kinase C. Exp Eye Res. 1995;60:683–695.
  • Sakamoto T, Hinton DR, Kimura H, Spee C, Gopalakrish-na R, Ryan SJ. Vitamin E succinate inhibits prolifera-tion and migration of retinal pigment epithelial cells in vitro: therapeutic implication for proliferative retinopa-thy. Graefe's Arch Clin Exp Ophthalmol. 1996;234: 186–192.
  • D'Amato R, Loughnan M, Flynn E, Folkman J. Thali-domide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA. 1994;91:4082–4085.
  • Smith JP, Solomon TE. Effect of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology. 1988;95:1541–1548.
  • Taylor JE, Moreau JP, Baptiste L, Moody TW. Octapep-tide analogues of somatostatin inhibit the clonal growth and vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cells. Pep-tides. 1991;12:839–843.
  • Grant MB, Wargovich TJ, Ellis EA, Caballero S, Mansour M, Pepine CJ. Localization of insulin-like growth fac-tor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells;a potential treatment for restenosis ? Cir-culation. 1994;89:1511–1517.
  • Grant MB, Caballero S, Millard WJ. Inhibition of IGF- I and b-FGF stimulated growth of human retinal endot-helial cells by the somatostatin analogue, octreotide: a potential treatment for ocular neovascularization. Regul Pept. 1993;20:267–278.
  • Folkman J, Ingber D. Angiostatic steroids. Ann Surg. 1987;206:374–382.
  • Bauer KS, Dixon SC, Figg WD. Inhibition of angiogen-esis by thalidomide requires metabolic activation, which is species-dependent. Biochem Pharmacol. 1998;55:1827–1834.
  • Parmar H, Bogden A, Mollard M, de Rouge B, Phillips RH, Lightman SL. Somatostatin and somatostatin ana-logues in oncology. Cancer Treat Rev. 1989;16:95–115.
  • Kothary PC, Varde N, Del Monte MA. Somatostatin inhibits human retinal pigment epithelial cell prolifera-tion (Abstract). Second International Symposium on Experimental and Clinical Pharmacology and Pharma-ceutics in Munich from 11. - 14. 09. 1997, 1997;:539.
  • Prevost G, Foehrlé E, Thomas F, Pihan I, Veber N, Starzec A, Israel L. Growth of human breast cancer cell lines is inhibited by somatostatin analog BIM23014. Endocri-nology. 1991;129:323–329.
  • Setyono-Han B, Henkelman MS, Foekens JA, Klijn JGM. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res. 1987;47:1566–1570.
  • Danesi R, Agen C, Benelli U, Paola AD, Nardini D, Bocci G, Basolo F, Campagni A, Tacca MD. Inhibition of experimental angiogenesis by the somatostatin analgoue. Clin Can Res. 1997;3:265–272.
  • Fiscella R, Peyman GA, Elvart J, Yue B. In vitro evalu-ation of cellular inhibitory potential of various antine-oplastic drugs and dexamethasone. Ophthalmic Surg. 1985;16:247–249.
  • Tano Y, Sugita G, Abrams G, Machemer R. Inhibition of intraocular proliferations with intravitreal corticoster-oids. Am J Ophthalmol. 1980;89:131–136.
  • Tano Y, Chandler D, Machemer R. Treatment of intraocu-lar proliferation with intravitreal injection of triamcino-lone acetonide. Am J Ophthalmol. 1980;90:810–816.
  • Blumenkranz MS, Claffin A, Hajek AS. Selection of therapeutic agents for intraocular proliferative disease: cell culture evaluation. Arch Ophthalmol. 1984;102:598–604.
  • Bourcier T, Borderie V, Forgez P, Lombet A, Rosene W, Laroche L. In vitro effect of dexamethasone on hu-man corneal keratocytes. Invest Ophthalmol Vis Sci.
  • Fyfe Al, Rosenthal A, Gotlieb Al. Immunosuppresive agents and endothelial repair. Prednisolone delays mi-gration and cytoskeletal rearrangement in wounded por-cine aortic monolayers. Arterioscler Thrombo. 1995;15:1166–1171.
  • ho H, Ake Y, Saegusa Y, Mizuno K. The effect of lipid peroxide on osteoblasts and vascular enoothelial cells - the possible role of ischemia-reperfusion in the progres-sion of avascular necrosis of the femoral head. Kobe J Med Sci. 1996;42:361–373.
  • Järveläinen H, Pelliniemi TT, Ronnemaa T. The stabi-lizing effect of glucocorticoids on human endothelial cells in culture. Scand J Clin Lab Invest. 1985;45:223–228.
  • Schönfeld C-L. Expression of the nuclear glucocorticoid receptor in the human retinal pigment epithelium. Oph-thalmologe. 1998;95:400–403.
  • O'Malley BW, Means AR. Female steroid hormones and target cell nuclei. The effect of steroid hormones on target cell nuclei are of major importance in the induction of new cell function. Science. 1974;183:610–620.
  • Frisch SM, Ruley HE. Transcription from the stromelysin promotor is induced by interleukin-1 and repressed by dexamethasone. J Biol Chem. 1987;262:16300–16304.
  • Sch8nfeld CL. Expression of the metalloproteinase stromelysin in the human retinalen pigment epithelium. Ophthalmologe. 1997;94:629–633.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.